Nephros Inc (NEPH) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Nephros Inc (NEPH) has a cash flow conversion efficiency ratio of -0.156x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.67 Million) by net assets ($10.70 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See NEPH cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Nephros Inc - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how Nephros Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Nephros Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nephros Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Star Equity Holdings Inc
NASDAQ:STRR
|
-0.059x |
|
Culp, Inc. Common Stock
NYSE:CULP
|
-0.022x |
|
Mr. Blue Corporation
KQ:207760
|
-0.006x |
|
US Energy Corp
NASDAQ:USEG
|
-0.006x |
|
ATA IMS Bhd
KLSE:8176
|
0.040x |
|
Jack Chia Industries (Thailand) Public Company Limited
BK:JCT
|
0.022x |
|
RMB Holdings Ltd
JSE:RMH
|
-0.015x |
|
Duksung
KO:004830
|
0.014x |
Annual Cash Flow Conversion Efficiency for Nephros Inc (2002–2025)
The table below shows the annual cash flow conversion efficiency of Nephros Inc from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see NEPH company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $10.20 Million | $1.65 Million | 0.161x | +381.36% |
| 2024-12-31 | $8.59 Million | $-492.00K | -0.057x | -157.92% |
| 2023-12-31 | $8.36 Million | $827.00K | 0.099x | +127.17% |
| 2022-12-31 | $8.88 Million | $-3.23 Million | -0.364x | -279.03% |
| 2021-12-31 | $14.75 Million | $-1.42 Million | -0.096x | +78.33% |
| 2020-12-31 | $15.57 Million | $-6.90 Million | -0.443x | -49.75% |
| 2019-12-31 | $7.69 Million | $-2.28 Million | -0.296x | +45.05% |
| 2018-12-31 | $6.80 Million | $-3.66 Million | -0.539x | -1264.21% |
| 2017-12-31 | $1.95 Million | $-77.00K | -0.039x | +98.75% |
| 2016-12-31 | $667.00K | $-2.11 Million | -3.166x | -121.11% |
| 2015-12-31 | $2.66 Million | $-3.81 Million | -1.432x | -426.07% |
| 2014-12-31 | $-5.68 Million | $-2.50 Million | 0.439x | -92.52% |
| 2013-12-31 | $-610.00K | $-3.58 Million | 5.874x | +125.91% |
| 2012-12-31 | $-595.00K | $-1.55 Million | 2.600x | +385.08% |
| 2011-12-31 | $1.42 Million | $-1.30 Million | -0.912x | +90.47% |
| 2010-12-31 | $135.00K | $-1.29 Million | -9.570x | -617.41% |
| 2009-12-31 | $1.96 Million | $-2.61 Million | -1.334x | +40.95% |
| 2008-12-31 | $2.53 Million | $-5.72 Million | -2.259x | -166.10% |
| 2007-12-31 | $8.76 Million | $-7.43 Million | -0.849x | -124.38% |
| 2006-12-31 | $-2.10 Million | $-7.30 Million | 3.482x | +470.79% |
| 2005-12-31 | $5.38 Million | $-5.05 Million | -0.939x | -15.62% |
| 2004-12-31 | $9.65 Million | $-7.84 Million | -0.812x | -228.14% |
| 2003-12-31 | $-5.38 Million | $-3.41 Million | 0.634x | +180.58% |
| 2002-12-31 | $-8.00 Million | $-1.81 Million | 0.226x | -- |
About Nephros Inc
Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella a… Read more